Clinical trial · Observational
Endoscopic Treatment of Bronchial Carcinoid Tumors
Feasibility and Therapeutic Method of Endoscopic Treatment of Bronchial Carcinoid Tumors: 22 Years Experience of Saint-Etienne
NCT03723499CI-TRIAL-00035488completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoid Tumor | Neuroendocrine Tumor | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Medical data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- endoscopic treatment
- description
- Patient with endoscopic treatment will be included. Some medical data collection by medical record will be collected.
- interventionNames
- Other: Medical data collection
Primary outcomes (1)
- measure
- Complete endoscopic treatment
- timeFrame
- Month 1
- description
- patients who have a complete endoscopic treatment
Secondary outcomes (3)
- measure
- Type of endoscopic method used
- timeFrame
- Month 1
- description
- Analysis type of endoscopic method used.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients treated by endoscopic approach for a carcinoid tumor at the University Hospital Centre of Saint-Etienne between November 1995 to December 2017. Exclusion Criteria: * Patients treated for a recurrence of carcinoid tumor. * Patients with metastatic disease.
References
Publications (0)
Data not yet available
No reference posted for this study.